AEREM LIMITED

Financial Health Score: D+ (Vulnerable)

Aerem Limited is currently in a state of acute financial distress. While the company remains technically solvent, it is exhibiting severe symptoms of operational illness, including heavy financial hemorrhaging, a rapid decline in equity health, and a dangerous reliance on external life support. Immediate intervention is required to stop the bleeding and stabilize the patient.

1. Key Vital Signs

• Pulse (Profitability): Weak and erratic. The company suffered a severe loss of £61,515 in the year ending March 2025, a stark contrast to the retained earnings of £127,147 at the start of the period. This is a financial hemorrhage that has halved the company's equity in just twelve months.
• Blood Pressure (Liquidity): Dangerously low. Cash reserves dropped by 29%, falling from £60,744 to £43,094. While the current ratio sits at roughly 1.28 (£124,952 current assets / £97,704 current liabilities), this figure masks a dangerous underlying condition. A significant portion of current assets is tied up in an inter-company loan (£67,960), which is restricting healthy cash circulation.
• Cholesterol (Liabilities): Blockage detected. Trade creditors surged from a manageable £1,235 to £28,278—a massive increase that suggests the company is struggling to pay its suppliers on time. This financial plaque is restricting the flow of business operations.
• Weight (Assets): Atrophy. Total assets shrank from £157,713 to £124,952. The business is actively consuming its own muscle mass to survive, rather than building strength.

2. Symptoms Analysis

The numbers reveal a business suffering from a compromised immune system:

• The Hemorrhage (Operating Loss): A £61k loss for a micro-entity is the equivalent of a major arterial bleed. The retained earnings have dropped from £127k to £65k. If this rate of loss continues, the company will face insolvency within 12 to 18 months.
• Blocked Arteries (Inter-company Debt): Camvale Ltd, a company under common control, owes Aerem £67,960. This sum represents over 54% of the company's total assets. Money tied up here is suffocating Aerem’s working capital.
• Life Support (Director Loan): The company owes its director, M C Scrace, £66,491. While this creditor balance acts as a financial ventilator—keeping the company alive by not demanding repayment—it also indicates that the business cannot sustain itself through its own operational cash flow.
• Inflammation (Trade Creditors): The 20x increase in trade creditors is a classic symptom of a business stretching its payment terms to preserve cash, indicating suppliers may be losing patience.

3. Diagnosis: Acute Operational Distress

Aerem Limited is suffering from Severe Cash Flow Malnutrition compounded by an Operational Deficit.

The core business (manufacturing non-domestic cooling and ventilation equipment) is currently generating insufficient revenue to cover its costs, resulting in heavy losses. The company is only surviving because it is being kept on life support via the director's loan, which subordinates the company's debts to the director rather than external creditors. Meanwhile, the inter-company receivable from Camvale Ltd represents a severe blockage; if this debt were called in or written off, Aerem would suffer a potentially fatal shock to its balance sheet.

4. Recommendations: Prescribed Treatment Plan

To restore financial wellness, the following immediate interventions are required:

1. Emergency Triage (Stop the Losses): Conduct an immediate review of overheads and operational costs. The monthly cash burn rate must be reduced immediately to prevent the complete erosion of shareholder funds.
2. Clear the Blockages (Collect Inter-company Debt): The £67,960 owed by Camvale Ltd must be collected. As a related party, the director must ensure this loan is repaid to Aerem Limited to inject vital working capital into the struggling business.
3. Manage the Inflammation (Supplier Relations): Communicate proactively with trade creditors. The sudden spike in unpaid bills risks supply chain failure if suppliers impose credit limits or demand cash on delivery.
4. Financial Physiotherapy (Revenue Generation): Focus on high-margin sales and strict working capital management. The business needs to rebuild its cash reserves independently rather than relying on the director's loan for survival.